Eagle Pharmaceuticals Filing Shows Danaos Corporation Reports 9.99% Passive Stake In Co As Of June 6, 2023
Portfolio Pulse from Benzinga Newsdesk
Danaos Corporation has reported a 9.99% passive stake in Eagle Pharmaceuticals as of June 6, 2023, according to a recent SEC filing.
June 16, 2023 | 8:28 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Eagle Pharmaceuticals (EGRX) sees a 9.99% passive stake acquisition by Danaos Corporation as of June 6, 2023.
Danaos Corporation's acquisition of a 9.99% passive stake in Eagle Pharmaceuticals (EGRX) indicates a significant investment and confidence in the company. This news is likely to have a positive impact on EGRX's stock price in the short term as it shows increased interest from investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100